tiprankstipranks
Alnylam Pharmaceuticals (GB:0HD2)
:0HD2

Alnylam Pharma (0HD2) Similar Shares

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$238.10
$30.91B
61.34%
16 Buy
3 Hold
0 Sell
Strong Buy
Arrowhead Pharmaceuticals
$15.06
$1.92B
-47.25%
7 Buy
4 Hold
0 Sell
Moderate Buy
Biogen
$143.66
$21.03B
12.85
-36.81%
12 Buy
12 Hold
0 Sell
Moderate Buy
Ionis Pharmaceuticals
$33.03
$5.25B
-23.49%
10 Buy
6 Hold
0 Sell
Moderate Buy
Vertex Pharmaceuticals
$488.34
$128.40B
18.40%
15 Buy
11 Hold
1 Sell
Moderate Buy
Sarepta Therapeutics
$100.71
$9.77B
42.25
-17.45%
16 Buy
2 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0HD2
Alnylam Pharma
238.10
90.52
61.34%
ARWR
Arrowhead Pharmaceuticals
15.06
-13.49
-47.25%
BIIB
Biogen
143.66
-83.70
-36.81%
IONS
Ionis Pharmaceuticals
33.03
-10.14
-23.49%
VRTX
Vertex Pharmaceuticals
488.34
75.89
18.40%
SRPT
Sarepta Therapeutics
100.71
-21.29
-17.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis